ROCK inhibitor 3   

GtoPdb Ligand ID: 10425

Synonyms: Chiesi Rock inhibitor [2] | example 3 [WO2010032875A2] [3]
Compound class: Synthetic organic
Comment: Inhibitor 3 is a selectve and potent inhibitor of the Rho-associated kinases, ROCK1 and ROCK2. The chemical structure presented here was drawn from Cantoni et al., 2019 [1]. PubChem CID 46182713 presents the compound without specified stereochemistry.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 103.26
Molecular weight 282.15
XLogP 1.35
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES COc1nc(NC2CCC(CC2)N)c(cc1C(=O)N)F
Isomeric SMILES COc1nc(N[C@@H]2CC[C@H](CC2)N)c(cc1C(=O)N)F
InChI InChI=1S/C13H19FN4O2/c1-20-13-9(11(16)19)6-10(14)12(18-13)17-8-4-2-7(15)3-5-8/h6-8H,2-5,15H2,1H3,(H2,16,19)(H,17,18)/t7-,8-
InChI Key IMZIJLMIOSQRGE-ZKCHVHJHSA-N
References
1. Cantoni S, Cavalli S, Pastore F, Accetta A, Pala D, Vaccaro F, Cesari N, De Logu F, Nassini R, Villetti G et al.. (2019)
Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension.
Eur. J. Pharmacol., 850: 126-134. [PMID:30753868]
2. Dayal N, Mikek CG, Hernandez D, Naclerio GA, Yin Chu EF, Carter-Cooper BA, Lapidus RG, Sintim HO. (2019)
Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors.
Eur J Med Chem, 180: 449-456. DOI: 10.1016/j.ejmech.2019.06.089 [PMID:31330446]
3. Terasawa T, Shigenaga S, Itoh S, Maeda J, Watanabe H, Kubo S, Ishii N. (2010)
Heterocyclic carboxamide compounds.
Patent number: WO2010032875A2. Assignee: Astellas Pharma Inc.. Priority date: 18/09/2008. Publication date: 25/03/2010.